HPd1 Products


Description

Stem cells offer a therapeutic promise for many diseases. In the case of diabetes, stem cells offer the promise that beta cells may be generated ex vivo for the possible transplantation and cure of Type I diabetes (Couri CE, et al.). For this to happen, stem cells will need to be isolated and expanded, they will need to be differentiated toward the beta cell lineage, and the differentiated cell progeny used for transplantation may need to be isolated from complex cell mixtures following differentiation. Appropriate markers targeting cell surface molecules on developing and mature pancreatic cells will be required for such research.

Bioinformatics

Uniprot Human
Alternate Names
  • PD1
  • human pancreatic duct cell
  • SLEB2
  • Protein PD 1
  • Programmed Cell Death Protein 1
  • Programmed cell death 1
  • PDCD1
  • PDCD 1
  • PD-1
  • PD1
  • PD 1
  • hPD 1
  • CD279 antigen
  • CD279
  • PD1
  • human pancreatic duct cell
  • SLEB2
  • Protein PD 1
  • Programmed Cell Death Protein 1
  • Programmed cell death 1
  • PDCD1
  • PDCD 1
  • PD-1
  • PD1
  • PD 1
  • hPD 1
  • CD279 antigen
  • CD279
  • PD1
  • human pancreatic duct cell
  • SLEB2
  • Protein PD 1
  • Programmed Cell Death Protein 1
  • Programmed cell death 1
  • PDCD1
  • PDCD 1
  • PD-1
  • PD1
  • PD 1
  • hPD 1
  • CD279 antigen
  • CD279
  • PD1
  • human pancreatic duct cell
  • SLEB2
  • Protein PD 1
  • Programmed Cell Death Protein 1
  • Programmed cell death 1
  • PDCD1
  • PDCD 1
  • PD-1
  • PD1
  • PD 1
  • hPD 1
  • CD279 antigen
  • CD279

Research Areas for HPd1

Find related products by research area and learn more about each of the different research areas below.

Adaptive Immunity
Apoptosis
Cell Biology
Immunology
Pancreatic Stem Cell Markers
Stem Cell Markers